The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Monogenic Disease Testing Market Research Report 2025

Global Monogenic Disease Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1800571

No of Pages : 78

Synopsis
The global Monogenic Disease Testing market was valued at US$ 92 million in 2023 and is anticipated to reach US$ 146.2 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
North American market for Monogenic Disease Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Monogenic Disease Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Monogenic Disease Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Monogenic Disease Testing include Celera Support Services, Abbott, ELITech Group, Auto Genomics, PerkinElmer and Bio-Rad Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Monogenic Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monogenic Disease Testing.
Report Scope
The Monogenic Disease Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monogenic Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monogenic Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Celera Support Services
Abbott
ELITech Group
Auto Genomics
PerkinElmer
Bio-Rad Laboratories
Segment by Type
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive and Pre-Symptomatic Testing
Prenatal Testing
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monogenic Disease Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monogenic Disease Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Carrier Testing
1.2.3 Diagnostic Testing
1.2.4 New-Born Screening
1.2.5 Predictive and Pre-Symptomatic Testing
1.2.6 Prenatal Testing
1.3 Market by Application
1.3.1 Global Monogenic Disease Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monogenic Disease Testing Market Perspective (2019-2030)
2.2 Monogenic Disease Testing Growth Trends by Region
2.2.1 Global Monogenic Disease Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Monogenic Disease Testing Historic Market Size by Region (2019-2024)
2.2.3 Monogenic Disease Testing Forecasted Market Size by Region (2025-2030)
2.3 Monogenic Disease Testing Market Dynamics
2.3.1 Monogenic Disease Testing Industry Trends
2.3.2 Monogenic Disease Testing Market Drivers
2.3.3 Monogenic Disease Testing Market Challenges
2.3.4 Monogenic Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monogenic Disease Testing Players by Revenue
3.1.1 Global Top Monogenic Disease Testing Players by Revenue (2019-2024)
3.1.2 Global Monogenic Disease Testing Revenue Market Share by Players (2019-2024)
3.2 Global Monogenic Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monogenic Disease Testing Revenue
3.4 Global Monogenic Disease Testing Market Concentration Ratio
3.4.1 Global Monogenic Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monogenic Disease Testing Revenue in 2023
3.5 Monogenic Disease Testing Key Players Head office and Area Served
3.6 Key Players Monogenic Disease Testing Product Solution and Service
3.7 Date of Enter into Monogenic Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monogenic Disease Testing Breakdown Data by Type
4.1 Global Monogenic Disease Testing Historic Market Size by Type (2019-2024)
4.2 Global Monogenic Disease Testing Forecasted Market Size by Type (2025-2030)
5 Monogenic Disease Testing Breakdown Data by Application
5.1 Global Monogenic Disease Testing Historic Market Size by Application (2019-2024)
5.2 Global Monogenic Disease Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Monogenic Disease Testing Market Size (2019-2030)
6.2 North America Monogenic Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Monogenic Disease Testing Market Size by Country (2019-2024)
6.4 North America Monogenic Disease Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monogenic Disease Testing Market Size (2019-2030)
7.2 Europe Monogenic Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Monogenic Disease Testing Market Size by Country (2019-2024)
7.4 Europe Monogenic Disease Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monogenic Disease Testing Market Size (2019-2030)
8.2 Asia-Pacific Monogenic Disease Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Monogenic Disease Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Monogenic Disease Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monogenic Disease Testing Market Size (2019-2030)
9.2 Latin America Monogenic Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Monogenic Disease Testing Market Size by Country (2019-2024)
9.4 Latin America Monogenic Disease Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monogenic Disease Testing Market Size (2019-2030)
10.2 Middle East & Africa Monogenic Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Monogenic Disease Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Monogenic Disease Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Celera Support Services
11.1.1 Celera Support Services Company Detail
11.1.2 Celera Support Services Business Overview
11.1.3 Celera Support Services Monogenic Disease Testing Introduction
11.1.4 Celera Support Services Revenue in Monogenic Disease Testing Business (2019-2024)
11.1.5 Celera Support Services Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Monogenic Disease Testing Introduction
11.2.4 Abbott Revenue in Monogenic Disease Testing Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 ELITech Group
11.3.1 ELITech Group Company Detail
11.3.2 ELITech Group Business Overview
11.3.3 ELITech Group Monogenic Disease Testing Introduction
11.3.4 ELITech Group Revenue in Monogenic Disease Testing Business (2019-2024)
11.3.5 ELITech Group Recent Development
11.4 Auto Genomics
11.4.1 Auto Genomics Company Detail
11.4.2 Auto Genomics Business Overview
11.4.3 Auto Genomics Monogenic Disease Testing Introduction
11.4.4 Auto Genomics Revenue in Monogenic Disease Testing Business (2019-2024)
11.4.5 Auto Genomics Recent Development
11.5 PerkinElmer
11.5.1 PerkinElmer Company Detail
11.5.2 PerkinElmer Business Overview
11.5.3 PerkinElmer Monogenic Disease Testing Introduction
11.5.4 PerkinElmer Revenue in Monogenic Disease Testing Business (2019-2024)
11.5.5 PerkinElmer Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Detail
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Monogenic Disease Testing Introduction
11.6.4 Bio-Rad Laboratories Revenue in Monogenic Disease Testing Business (2019-2024)
11.6.5 Bio-Rad Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Monogenic Disease Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Carrier Testing
Table 3. Key Players of Diagnostic Testing
Table 4. Key Players of New-Born Screening
Table 5. Key Players of Predictive and Pre-Symptomatic Testing
Table 6. Key Players of Prenatal Testing
Table 7. Global Monogenic Disease Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Monogenic Disease Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Monogenic Disease Testing Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Monogenic Disease Testing Market Share by Region (2019-2024)
Table 11. Global Monogenic Disease Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Monogenic Disease Testing Market Share by Region (2025-2030)
Table 13. Monogenic Disease Testing Market Trends
Table 14. Monogenic Disease Testing Market Drivers
Table 15. Monogenic Disease Testing Market Challenges
Table 16. Monogenic Disease Testing Market Restraints
Table 17. Global Monogenic Disease Testing Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Monogenic Disease Testing Market Share by Players (2019-2024)
Table 19. Global Top Monogenic Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenic Disease Testing as of 2023)
Table 20. Ranking of Global Top Monogenic Disease Testing Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Monogenic Disease Testing Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Monogenic Disease Testing Product Solution and Service
Table 24. Date of Enter into Monogenic Disease Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Monogenic Disease Testing Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Monogenic Disease Testing Revenue Market Share by Type (2019-2024)
Table 28. Global Monogenic Disease Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Monogenic Disease Testing Revenue Market Share by Type (2025-2030)
Table 30. Global Monogenic Disease Testing Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Monogenic Disease Testing Revenue Market Share by Application (2019-2024)
Table 32. Global Monogenic Disease Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Monogenic Disease Testing Revenue Market Share by Application (2025-2030)
Table 34. North America Monogenic Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Monogenic Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Monogenic Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Monogenic Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Monogenic Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Monogenic Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Monogenic Disease Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Monogenic Disease Testing Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Monogenic Disease Testing Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Monogenic Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Monogenic Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Monogenic Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Monogenic Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Monogenic Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Monogenic Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 49. Celera Support Services Company Detail
Table 50. Celera Support Services Business Overview
Table 51. Celera Support Services Monogenic Disease Testing Product
Table 52. Celera Support Services Revenue in Monogenic Disease Testing Business (2019-2024) & (US$ Million)
Table 53. Celera Support Services Recent Development
Table 54. Abbott Company Detail
Table 55. Abbott Business Overview
Table 56. Abbott Monogenic Disease Testing Product
Table 57. Abbott Revenue in Monogenic Disease Testing Business (2019-2024) & (US$ Million)
Table 58. Abbott Recent Development
Table 59. ELITech Group Company Detail
Table 60. ELITech Group Business Overview
Table 61. ELITech Group Monogenic Disease Testing Product
Table 62. ELITech Group Revenue in Monogenic Disease Testing Business (2019-2024) & (US$ Million)
Table 63. ELITech Group Recent Development
Table 64. Auto Genomics Company Detail
Table 65. Auto Genomics Business Overview
Table 66. Auto Genomics Monogenic Disease Testing Product
Table 67. Auto Genomics Revenue in Monogenic Disease Testing Business (2019-2024) & (US$ Million)
Table 68. Auto Genomics Recent Development
Table 69. PerkinElmer Company Detail
Table 70. PerkinElmer Business Overview
Table 71. PerkinElmer Monogenic Disease Testing Product
Table 72. PerkinElmer Revenue in Monogenic Disease Testing Business (2019-2024) & (US$ Million)
Table 73. PerkinElmer Recent Development
Table 74. Bio-Rad Laboratories Company Detail
Table 75. Bio-Rad Laboratories Business Overview
Table 76. Bio-Rad Laboratories Monogenic Disease Testing Product
Table 77. Bio-Rad Laboratories Revenue in Monogenic Disease Testing Business (2019-2024) & (US$ Million)
Table 78. Bio-Rad Laboratories Recent Development
Table 79. Research Programs/Design for This Report
Table 80. Key Data Information from Secondary Sources
Table 81. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monogenic Disease Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Monogenic Disease Testing Market Share by Type: 2023 VS 2030
Figure 3. Carrier Testing Features
Figure 4. Diagnostic Testing Features
Figure 5. New-Born Screening Features
Figure 6. Predictive and Pre-Symptomatic Testing Features
Figure 7. Prenatal Testing Features
Figure 8. Global Monogenic Disease Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Monogenic Disease Testing Market Share by Application: 2023 VS 2030
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Monogenic Disease Testing Report Years Considered
Figure 14. Global Monogenic Disease Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Monogenic Disease Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Monogenic Disease Testing Market Share by Region: 2023 VS 2030
Figure 17. Global Monogenic Disease Testing Market Share by Players in 2023
Figure 18. Global Top Monogenic Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenic Disease Testing as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Monogenic Disease Testing Revenue in 2023
Figure 20. North America Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Monogenic Disease Testing Market Share by Country (2019-2030)
Figure 22. United States Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Monogenic Disease Testing Market Share by Country (2019-2030)
Figure 26. Germany Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Monogenic Disease Testing Market Share by Region (2019-2030)
Figure 34. China Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Monogenic Disease Testing Market Share by Country (2019-2030)
Figure 42. Mexico Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Monogenic Disease Testing Market Share by Country (2019-2030)
Figure 46. Turkey Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Monogenic Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Celera Support Services Revenue Growth Rate in Monogenic Disease Testing Business (2019-2024)
Figure 49. Abbott Revenue Growth Rate in Monogenic Disease Testing Business (2019-2024)
Figure 50. ELITech Group Revenue Growth Rate in Monogenic Disease Testing Business (2019-2024)
Figure 51. Auto Genomics Revenue Growth Rate in Monogenic Disease Testing Business (2019-2024)
Figure 52. PerkinElmer Revenue Growth Rate in Monogenic Disease Testing Business (2019-2024)
Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Monogenic Disease Testing Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’